newsZotiraciclib granted Orphan Drug Designation by FDA and EMA6 December 2019 | By Hannah Balfour (European Pharmaceutical Review)The FDA and EMA have granted Orphan Drug Designation to zotiraciclib, currently the subject of two separate Phase Ib clinical trials in glioblastoma.
newsPAC-1-temozolomide combination shows promise for anaplastic astrocytoma29 November 2017 | By Dr Zara Kassam (European Pharmaceutical Review)A drug that spurs cancer cells to self-destruct has been cleared for use in a clinical trial of patients with anaplastic astrocytoma...